VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VNDA

<< 前へ 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2017/11/08	06 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/11/08	06 : 01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/10/25	06 : 00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/10/18	20 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/10/11	07 : 15	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/10/02	22 : 15	PR Newswire (US)	Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/09/30	02 : 00	PR Newswire (US)	Vanda to Present Scientific Posters at World Sleep 2017	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/09/14	06 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/09/14	05 : 04	PR Newswire (US)	Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/09/12	06 : 00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/09/07	06 : 00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/08/03	20 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/08/03	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/08/03	05 : 01	PR Newswire (US)	Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/07/21	20 : 00	PR Newswire (US)	Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatme...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/07/17	22 : 00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/07/11	03 : 20	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/26	22 : 06	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/20	06 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/20	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/20	06 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/20	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/20	05 : 24	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/16	05 : 49	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/16	05 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/06/06	06 : 00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at June 2017 Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/05/05	03 : 10	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/05/03	20 : 05	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/05/03	05 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2017/05/03	05 : 01	PR Newswire (US)	Vanda Pharmaceuticals Reports First Quarter 2017 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc